reference/17000556

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17000556

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1394
issn	1473-3099
issueIdentifier	10
pageRange	1383-1394
publicationName	The Lancet. Infectious diseases
startingPage	1383
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_665c6efce5eca061f87bb5cdb2b63a10 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ab37b23cddcdc0483823ed3da9e86b2c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1761d5496e6554a546587f74482f155f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5a0cf12d7bfc0cc54e77f524709531de
bibliographicCitation	Chappell KJ, Mordant FL, Li Z, Wijesundara DK, Ellenberg P, Lackenby JA, Cheung STM, Modhiran N, Avumegah MS, Henderson CL, Hoger K, Griffin P, Bennet J, Hensen L, Zhang W, Nguyen THO, Marrero-Hernandez S, Selva KJ, Chung AW, Tran MH, Tapley P, Barnes J, Reading PC, Nicholson S, Corby S, Holgate T, Wines BD, Hogarth PM, Kedzierska K, Purcell DFJ, Ranasinghe C, Subbarao K, Watterson D, Young PR, Munro TP. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Infectious Diseases. 2021 Oct;21(10):1383–94. doi: 10.1016/s1473-3099(21)00200-0.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_037616ac7e33cd192aa480c8235be480 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_feced1fd69194c4a8426b4a934a487ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a4987be289d7c71c9965dc2e491f510 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78539427fa3016e8e195c83c547b5a6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e98a347b951d745683a4cfb77fbe6ef7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b654013757d0904b1bfb47c700d2fa5e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cf500e508122efca829bc5b2e924bda http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebfbcc9d5fa6b7309b06af1372f49e22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69c796c0eda63254f1faf034cda453fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e9ad619d855d6e40ce19196ba8f1e3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3870a957f254c40e844a7395d26f6a96 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_900e301b5f7ee7a00d6df479be3eaa76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60efa0a48e2d28ca825233bc35e6a99e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e0ef753a62ab7585f4d13c21c1b5f90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3cfc03eb4b163a1b267e332fa92c0c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd034583e8b0f7b17c56daf6d016d726 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8edddf266602469435d35cfe666d9c3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec40c1396f7f8f404dbdd134e96bf263 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15d6f103ae45290a537b4050d8501cc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67c761c0ed66a56d8d46893af52b3aba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b68f63057c8218395a3bbd5fbdcd3174 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b077c5d6a7378ebcc6bf1d053942cd4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b77e7a617e30c6f0bb73a90267f94000 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_513b7de77840fa5ece8f64e5bf605ed5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b42948390e7ee5145357e784b942d16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2c605f3b8c2032b246a78b8c3bc7f5f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bee36e5b7c69e97222a8868d8c21cc61 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8467-8537 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36f028a6f80e706e03eec609c06604e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f39ad5c251e80a00c2c20369e4654c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8404edb98c3c4359e3184f299f8558d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdd2515bf8deb1fd094a64cbd48ba2af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53cacdc2d26cd4b9ec6ac1de626178b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12631d75185546a004508e6ce68aa28b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdc6766d21efa46e46b88bd5fce8c3cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee8c047aab5c626a63a6048f7fe9e052
date	202110
identifier	https://doi.org/10.1016/s1473-3099%2821%2900200-0 https://pubmed.ncbi.nlm.nih.gov/PMC8055208 https://pubmed.ncbi.nlm.nih.gov/33887208
isPartOf	https://portal.issn.org/resource/ISSN/1473-3099 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27022
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
discusses	http://id.nlm.nih.gov/mesh/M0001361 http://id.nlm.nih.gov/mesh/M0534745 http://id.nlm.nih.gov/mesh/M000732754 http://id.nlm.nih.gov/mesh/M000683757 http://id.nlm.nih.gov/mesh/M0017253 http://id.nlm.nih.gov/mesh/M0020400 http://id.nlm.nih.gov/mesh/M0581462 http://id.nlm.nih.gov/mesh/M0237753 http://id.nlm.nih.gov/mesh/M0000431
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000086382Q000517 http://id.nlm.nih.gov/mesh/D000086663Q000008 http://id.nlm.nih.gov/mesh/D000276Q000494 http://id.nlm.nih.gov/mesh/D013185Q000276 http://id.nlm.nih.gov/mesh/D064370Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001315 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D057134Q000097 http://id.nlm.nih.gov/mesh/D014611Q000009 http://id.nlm.nih.gov/mesh/D000914Q000097 http://id.nlm.nih.gov/mesh/D058873Q000517 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D064368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011136 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638072 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762

Showing number of triples: 1 to 87 of 87.